This content is restricted.
Brief
"On "26/12/2024", the "Korea Food and Drug Administration (KFDA)" issued an update regarding "Ministry of Food and Drug Safety publishes 'Collection of Key Improvements in Preliminary GMP Surveys of Overseas Biopharmaceutical Manufacturing Sites'". The document aims to provide guidance on the key improvements in preliminary GMP surveys, helping industries to reduce processing times for import product approval. It highlights 9 major evaluation areas, providing case-specific examples and explanations."
Highlights content goes here...
This content is restricted.

RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested